Can This High-Yield Dividend Stock Keep Beating the S&P 500?
Dividend stocks are potent instruments for building wealth. A staggering 85% of the S 500's total returns since 1960 have emanated from dividend payouts, according to a report by Hartford Funds.
Amgen (NASDAQ: AMGN), a top-tier U.S. biotech firm, has been a coveted dividend stock since it began regular distributions to shareholders in 2011. Highlighting this fact, the company's shares have significantly outperformed the S 500 during this time.
Source Fool.com
Amgen Inc. Stock
€289.20
10.960%
With 23 Buy predictions and not a single Sell prediction Amgen Inc. is an absolute favorite of our community.
As a result the target price of 298 € shows a slightly positive potential of 3.04% compared to the current price of 289.2 € for Amgen Inc..
